Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 21 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

24%

5 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
9(52.9%)
Phase 4
4(23.5%)
Phase 2
2(11.8%)
Phase 1
1(5.9%)
Phase 3
1(5.9%)
17Total
N/A(9)
Phase 4(4)
Phase 2(2)
Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (21)

Showing 20 of 21 trials
NCT07337291Not ApplicableCompleted

Double Stent for Biliary Stones in Cirrhotic Patients

Role: lead

NCT07331142Not ApplicableCompleted

CBD Stenting vs Non-Stenting for Choledocholithiasis

Role: lead

NCT06948279Not ApplicableCompleted

Immediate vs. Elective Endoscopic Removal of Large CBD Stones in High-Risk Elderly Patients

Role: lead

NCT06708572Not ApplicableRecruiting

Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia

Role: lead

NCT06384443Completed

Proton Pump Inhibitors in Cirrhotic Patients

Role: lead

NCT06227624Phase 3Completed

Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia

Role: lead

NCT05298852Completed

Non-invasive Predictors of ICU Admission and Mortality in Initially Asymptomatic COVID-19 Patients

Role: collaborator

NCT05184491Phase 4Unknown

Nitazoxanide and Lansoprazole Based Regimens for H. Pylori Management

Role: lead

NCT04071197Not ApplicableUnknown

Gastrostomy-Biliary Diversion: Innovative Management for Bile Canalicular Transport Disorders

Role: lead

NCT04043858Not ApplicableUnknown

Safety and Efficacy of Midodrine Hydrochloride in the Management of Refractory Ascites Due to Cirrhosis in Children

Role: lead

NCT04099875Unknown

Ultrasonography for Nutritional Assesment in Cirrhotic Patients

Role: lead

NCT04385147Completed

Advanced Endoscopy During COVID-19

Role: collaborator

NCT03764345Not ApplicableCompleted

Eight Weeks Sofosbovir/Ledipasvir in HCV Infected Children Aged 4 to 10 Years

Role: lead

NCT02375867Phase 4Completed

Steroids in Fulminant Hepatitis A in the Pediatric Age Group

Role: lead

NCT02985281Phase 2Unknown

Safety and Efficacy of Gratisovir (Sofosbuvir)- Ribavirin Therapy in Pediatric Patients

Role: lead

NCT02059460Phase 4Completed

Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney

Role: lead

NCT02414880Phase 4Completed

Sugammadex Versus Neostigmine in Patients With Liver Cirrhosis Undergoing Liver Resection

Role: collaborator

NCT01197157Phase 2Completed

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

Role: lead

NCT02144389Not ApplicableCompleted

Arachidonic Acid Treatment Against Schistosomiasis Infection in Children

Role: collaborator

NCT02027493Not ApplicableCompleted

Hansenula-Derived Pegylated-Interferon Alpha-2a in Egyptian Children With Chronic HCV

Role: lead